Using nanoparticles to improve imaging and treatment of ectopic pregnancy
Nanoparticle-mediated placental imaging and magnetic hyperthermia for management of ectopic pregnancy
This study is testing a new imaging method that uses tiny particles to help doctors better spot ectopic pregnancies, which happen when a fertilized egg grows outside the uterus, so that women can get the right treatment faster and more safely.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oregon State University NIH-funded |
| Lab location | 1 site (Corvallis, United States) |
| Project ID | NIH-11059171 on NIH RePORTER |
What this research studies
This research focuses on developing a new imaging technique to better detect ectopic pregnancies, which occur when a fertilized egg implants outside the uterus, often in the fallopian tube. By utilizing nanoparticles that specifically target placental tissue, the study aims to enhance the accuracy of imaging methods like MRI, reducing the chances of misdiagnosis. The approach involves creating a biocompatible polymeric nanoplatform that can be injected into the bloodstream and will accumulate in the placenta without affecting the fetus. This could lead to more timely and effective treatments for ectopic pregnancies, potentially saving lives.
Who could benefit from this research
Good fit: Ideal candidates for this research are women who are in the early stages of pregnancy and are at risk for ectopic pregnancy.
Not a fit: Patients who are not pregnant or those with confirmed intrauterine pregnancies will not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the detection and management of ectopic pregnancies, reducing maternal mortality rates.
How similar studies have performed: Previous research has shown promise in using nanoparticles for targeted imaging, suggesting that this approach could be effective in improving ectopic pregnancy detection.
Where this research is happening
Corvallis, United States
- Oregon State University — Corvallis, United States (Active)
Researchers
- Principal investigator: Taratula, Olena — Oregon State University
- Study coordinator: Taratula, Olena
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.